Hot topics close

Chikungunya virus infection

Valneva Initiates Phase 3 Clinical Lot Consistency Study for its Single-Shot Chikungunya Vaccine Candidate
2
  • Valneva Initiates Phase 3 Clinical Lot Consistency Study for its Single-Shot Chikungunya Vaccine Candidate
  • Single-Shot Chikungunya Vaccine Candidate Launches Phase 3 Clinical Lot Consistency Study
This week's most popular news